Hiv Associated Lipodystrophy Syndrome
Mostrando 1-7 de 7 artigos, teses e dissertações.
-
1. Aerobic capacity and health-related quality of life in adults HIV-infected patients with and without lipodystrophy
Abstract Introduction HIV infection and its therapy which can affect their aerobic capacity and health-related quality of life of patients. Objective We conducted a cross-sectional study to determine if aerobic capacity and health related quality of life was decreased in HIV-infected patients receiving highly active antiretroviral therapy and comparing pat
Braz J Infect Dis. Publicado em: 2016-02
-
2. Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil
The aim of present study was to describe the frequency of lipodystrophy syndrome associated with HIV (LSHIV) and factors associated with dyslipidemia in Brazilian HIV infected children. HIV infected children on antiretroviral treatment were evaluated (nutritional assessment, physical examination, and laboratory tests) in this cross-sectional study. Univariat
Braz J Infect Dis. Publicado em: 2014-08
-
3. Prevalence and factors associated with lipodystrophy in AIDS patients
Introduction: The published literature shows an increased occurrence of adverse events, such as human immunodeficiency virus (HIV)-associated lipodystrophy syndrome, that are associated with the continuous use of antiretroviral therapy. This study was performed to estimate the prevalence and factors associated with lipodystrophy in acquired immune deficienc
Rev. Soc. Bras. Med. Trop.. Publicado em: 2014-01
-
4. Psychopathology and psychosocial adjustment in patients with HIV-associated lipodystrophy
OBJECTIVE: To study whether patients with HIV-1 associated lipodystrophy (LD) on highly active antiretroviral treatment (HAART) have more psychopathology and worse psychosocial adjustment than a similar group without this syndrome. METHODS: In a cross-sectional, observational study we compared 47 HIV-1 infected patients with LD (LD group) with 39 HIV-1 infec
Braz J Infect Dis. Publicado em: 2013-08
-
5. Estudo de dados e laboratoriais de pacientes com aids e lipodistrofia atendidos no Programa de Lipodistrofia do Hospital Heliópolis / Study of clinical and laboratory data of patients with AIDS and lipodystrophy met in Lipodystrophy Program of Heliopolis Hospital
INTRODUÇÃO: O termo lipodistrofia associada ao HIV foi introduzido aproximadamente dois anos após o início do uso dos inibidores da protease e, desde então, várias definições têm sido utilizadas para descrever a extensão das complicações morfológicas e metabólicas associadas à infecção pelo HIV e à terapia antirretroviral. Inúmeros estudos
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 07/10/2011
-
6. Polymorphism of the interleukin-18 and interferon-gamma in antiretroviral-associated lipodystrophy syndrome in HIV-1-infected patients. / Polimorfismo da interleucina-18 e do interferon gama na síndrome da lipodistrofia associada à terapia anti-retroviral em portadores do HIV-1
A introdução da terapia anti-retroviral de alta potência no tratamento da infecção pelo HIV reduziu significativamente as taxas de morbi-mortalidades relacionadas à imunodeficiência. Entretanto, o tratamento medicamentoso é acompanhado de vários efeitos colaterais, dentre eles, a síndrome da lipodistrofia (SL), caracterizada por alterações morfol
Publicado em: 2009
-
7. Lipid profile and body composition of HIV-1 infected patients treated with highly active antiretroviral therapy
Highly active antiretroviral therapy (HAART) has been associated with the development of a clinical group and metabolic disorders such as peripheral lipodystrophy syndrome in AIDS. The aim of this study was to analyze the lipid profile, the clinical aspects, and the body composition of HIV-1 infected individuals treated with or without protease inhibitor (PI
Journal of Venomous Animals and Toxins including Tropical Diseases. Publicado em: 2005-06